Obinutuzumab (GA101) Monotherapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Mantle-Cell Lymphoma: Results From the Phase II GAUGUIN Study
Overview of attention for article published in Journal of Clinical Oncology, July 2013
Altmetric Attention Score: 20
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (92nd percentile)
-
Good Attention Score compared to outputs of the same age and source (75th percentile)
Mentioned by
- 11 X users
- patent
- 2 patents
- f1000
- 1 research highlight platform
- guideline
- 2 clinical guideline sources
Readers on
- mendeley
- 137 Mendeley